6 Potential High-Yield Dividend Kings for Q2

The economy has made its way from “firmer ground” to “moderate growth”. Companies are looking to pay out some of their recently built up cash hoards and investors are happy to take it in. Here are 6 companies that have the ability to become second quarter dividend kings. Pfizer (PFE) is still enjoying New York tax breaks, and now fancies itself a biopharmaceutical company. The giant produces useful, well-known products such as Lipitor, Celebrex and Viagra. PFE is also established in the vaccine niche which can provide a healthy, almost “set it and forget it” cash flow. On the dividend front PFE has an above average current yield of 3.9%, which is in line with other pharmaceutical companies. At first glance the consistent dividend growth appears to be lacking as Pfizer has only increased payouts for the last 2 years. But a closer look will show that... Read more